21831303|t|Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-kappaB and MAPKs in BV-2 microglial cells.
21831303|a|BACKGROUND: Microglial activation plays an important role in neurodegenerative diseases through production of nitric oxide (NO) and several pro-inflammatory cytokines. Lipoxins (LXs) and aspirin-triggered LXs (ATLs) are considered to act as 'braking signals' in inflammation. In the present study, we investigated the effect of aspirin-triggered LXA4 (ATL) on infiammatory responses induced by lipopolysaccharide (LPS) in murine microglial BV-2 cells. METHODS: BV-2 cells were treated with ATL prior to LPS exposure, and the effects of such treatment production of nitric oxide (NO), inducible nitric oxide synthase (iNOS), interleukin-1beta (IL-1beta) and tumour necrosis factor-alpha (TNF-alpha) were analysed by Griess reaction, ELISA, western blotting and quantitative RT-PCR. Moreover, we investigated the effects of ATL on LPS-induced nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of mitogen-activated protein kinases (MAPKs) and activator protein-1 (AP-1) activation. RESULTS: ATL inhibited LPS-induced production of NO, IL-1beta and TNF-alpha in a concentration-dependent manner. mRNA expressions for iNOS, IL-1beta and TNF-alpha in response to LPS were also decreased by ATL. These effects were inhibited by Boc-2 (a LXA4 receptor antagonist). ATL significantly reduced nuclear translocation of NF-kappaB p65, degradation of the inhibitor IkappaB-alpha, and phosphorylation of extracellular signal-regulated kinase (ERK) and p38 MAPK in BV-2 cells activated with LPS. Furthermore, the DNA binding activity of NF-kappaB and AP-1 was blocked by ATL. CONCLUSIONS: This study indicates that ATL inhibits NO and pro-inflammatory cytokine production at least in part via NF-kappaB, ERK, p38 MAPK and AP-1 signaling pathways in LPS-activated microglia. Therefore, ATL may have therapeutic potential for various neurodegenerative diseases.
21831303	0	7	Aspirin	Chemical	MESH:D001241
21831303	18	28	lipoxin A4	Chemical	MESH:C040527
21831303	40	43	LPS	Chemical	MESH:D008070
21831303	56	68	inflammatory	Disease	MESH:D007249
21831303	107	116	NF-kappaB	Gene	18033
21831303	130	134	BV-2	CellLine	CVCL:0182
21831303	214	240	neurodegenerative diseases	Disease	MESH:D019636
21831303	263	275	nitric oxide	Chemical	MESH:D009569
21831303	297	309	inflammatory	Disease	MESH:D007249
21831303	340	347	aspirin	Chemical	MESH:D001241
21831303	415	427	inflammation	Disease	MESH:D007249
21831303	481	488	aspirin	Chemical	MESH:D001241
21831303	499	503	LXA4	Chemical	MESH:C040527
21831303	505	508	ATL	Chemical	-
21831303	547	565	lipopolysaccharide	Chemical	MESH:D008070
21831303	567	570	LPS	Chemical	MESH:D008070
21831303	575	581	murine	Species	10090
21831303	593	597	BV-2	CellLine	CVCL:0182
21831303	614	618	BV-2	CellLine	CVCL:0182
21831303	643	646	ATL	Chemical	-
21831303	656	659	LPS	Chemical	MESH:D008070
21831303	718	730	nitric oxide	Chemical	MESH:D009569
21831303	737	768	inducible nitric oxide synthase	Gene	18126
21831303	770	774	iNOS	Gene	18126
21831303	777	794	interleukin-1beta	Gene	16176
21831303	796	804	IL-1beta	Gene	16176
21831303	840	849	TNF-alpha	Gene	21926
21831303	975	978	ATL	Chemical	-
21831303	982	985	LPS	Chemical	MESH:D008070
21831303	994	1015	nuclear factor-kappaB	Gene	18033
21831303	1017	1026	NF-kappaB	Gene	18033
21831303	1105	1124	activator protein-1	Gene	16476
21831303	1126	1130	AP-1	Gene	16476
21831303	1153	1156	ATL	Chemical	-
21831303	1167	1170	LPS	Chemical	MESH:D008070
21831303	1197	1205	IL-1beta	Gene	16176
21831303	1210	1219	TNF-alpha	Gene	21926
21831303	1278	1282	iNOS	Gene	18126
21831303	1284	1292	IL-1beta	Gene	16176
21831303	1297	1306	TNF-alpha	Gene	21926
21831303	1322	1325	LPS	Chemical	MESH:D008070
21831303	1349	1352	ATL	Chemical	-
21831303	1386	1391	Boc-2	Chemical	-
21831303	1395	1408	LXA4 receptor	Gene	14294
21831303	1422	1425	ATL	Chemical	-
21831303	1517	1530	IkappaB-alpha	Gene	18035
21831303	1555	1592	extracellular signal-regulated kinase	Gene	26413
21831303	1594	1597	ERK	Gene	26413
21831303	1603	1611	p38 MAPK	Gene	26416
21831303	1615	1619	BV-2	CellLine	CVCL:0182
21831303	1641	1644	LPS	Chemical	MESH:D008070
21831303	1687	1696	NF-kappaB	Gene	18033
21831303	1701	1705	AP-1	Gene	16476
21831303	1721	1724	ATL	Chemical	-
21831303	1765	1768	ATL	Chemical	-
21831303	1789	1801	inflammatory	Disease	MESH:D007249
21831303	1843	1852	NF-kappaB	Gene	18033
21831303	1854	1857	ERK	Gene	26413
21831303	1859	1867	p38 MAPK	Gene	26416
21831303	1872	1876	AP-1	Gene	16476
21831303	1899	1902	LPS	Chemical	MESH:D008070
21831303	1935	1938	ATL	Chemical	-
21831303	1982	2008	neurodegenerative diseases	Disease	MESH:D019636
21831303	Association	MESH:D008070	26416
21831303	Positive_Correlation	MESH:C040527	MESH:D001241
21831303	Negative_Correlation	MESH:D001241	18033
21831303	Positive_Correlation	MESH:D008070	21926
21831303	Negative_Correlation	MESH:D001241	MESH:D008070
21831303	Negative_Correlation	MESH:C040527	18033
21831303	Positive_Correlation	MESH:D008070	16176
21831303	Association	MESH:D007249	26416
21831303	Negative_Correlation	MESH:C040527	MESH:D007249
21831303	Positive_Correlation	MESH:D008070	18126
21831303	Negative_Correlation	MESH:C040527	MESH:D008070
21831303	Association	MESH:D008070	26413
21831303	Positive_Correlation	MESH:D008070	18033
21831303	Negative_Correlation	MESH:D001241	MESH:D007249
21831303	Association	MESH:D008070	16476
21831303	Association	MESH:D009569	MESH:D019636
21831303	Positive_Correlation	MESH:D008070	MESH:D007249
21831303	Association	MESH:D007249	18033
21831303	Association	MESH:D007249	16476

